What question did this study set out to answer?

The aim is to develop a multifunctional graphene oxide nanoplatform combining proteasome inhibition and phototherapy for enhanced oral cancer treatment.

April 16, 2026Scientific Reports1 citationsOpen Access

Multimodal graphene oxide nanoplatform integrating proteasome inhibition and phototherapy for synergistic oral cancer treatment

SSShishira P. SBirla Institute of Technology and Science - Hyderabad Campus ZSZinataman SarkarBirla Institute of Technology and Science - Hyderabad Campus VAVarshini AreBirla Institute of Technology and Science - Hyderabad Campus

Key Points

The aim is to develop a multifunctional graphene oxide nanoplatform combining proteasome inhibition and phototherapy for enhanced oral cancer treatment.
Developed GO@PDA (BTZ, IR820) nanoparticles via loading proteasome inhibitor and photodynamic agent.
Characterized nanoparticles for size, morphology, and drug release efficiency.
Assessed cytotoxic effects in human hypopharyngeal squamous cell carcinoma spheroids.
Evaluated biochemical changes including ROS generation and ER stress-related protein expression.
GO@PDA (BTZ, IR820) NPs showed optimal photothermal conversion efficiency of 54.18%.
Demonstrated significant cytotoxicity with an IC50 of 18.53 ng/ml under laser exposure.
Induced mitochondrial dysfunction and cell cycle arrest leading to cell death.
Increased expression of ER stress markers CHOP, PERK, and BiP in FaDU spheroids.

Abstract

Multimodal therapeutic approaches hold the potential to revolutionize cancer treatment. Herein, we developed a chemo-photothermal-photodynamic therapeutic platform by loading a proteome inhibitor, BTZ, and photodynamic agent, IR820, into polydopamine-coated graphene oxide to form GO@PDA (BTZ, IR820) NPs. The developed NPs exhibit smaller particle size, homogeneous morphology, and laser-mediated drug release. The GO@PDA (BTZ, IR820) NPs exhibited an optimal photothermal conversion efficiency of 54.18%. GO@PDA (BTZ, IR820) NPs enhanced the uptake in the human hypopharyngeal squamous cell carcinoma (FaDU) spheroids and exhibited enhanced cytotoxicity (IC50: 18.53 ng/ml in the presence of laser). In vitro study in FaDU spheroid models also demonstrated mitochondrial dysfunction, reactive oxygen species (ROS) generation, and cell cycle arrest, leading to cancer cell death. The developed NPs also exhibited the BTZ-mediated expression of endoplasmic reticulum (ER) stress-related proteins, including CHOP, PERK, and BiP, leading to ER stress-mediated cell death in FaDU multicellular spheroids. The developed nanoplatform offers a synergistic multimodal therapeutic strategy and holds potential for tumor ablation in oral cancer.

AIに質問

Bookmark

View Full Paper